Apriem Advisors’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-1,197
Closed -$95K 439
2018
Q2
$95K Buy
+1,197
New +$99.4K 0.02% 185
2017
Q4
Sell
-21,475
Closed -$3.13M 152
2017
Q3
$3.13M Sell
21,475
-1,150
-5% -$157K 0.78% 33
2017
Q2
$2.94M Buy
22,625
+106
+0.5% +$13K 0.78% 36
2017
Q1
$2.8M Sell
22,519
-610
-3% -$73K 0.76% 34
2016
Q4
$2.68M Sell
23,129
-1,368
-6% -$152K 0.79% 35
2016
Q3
$2.56M Buy
24,497
+1,420
+6% +$154K 0.76% 37
2016
Q2
$2.28M Buy
23,077
+1,027
+5% +$106K 0.74% 35
2016
Q1
$2.21M Sell
22,050
-555
-2% -$57.1K 0.87% 31
2015
Q4
$2.71M Buy
22,605
+785
+4% +$90.8K 0.96% 34
2015
Q3
$2.36M Buy
21,820
+1,155
+6% +$143K 0.87% 34
2015
Q2
$2.39M Buy
20,665
+17,850
+634% +$2.04M 0.82% 39
2015
Q1
$325K Buy
2,815
+1,900
+208% +$227K 0.11% 78
2014
Q4
$102K Buy
915
+215
+31% +$22.7K 0.04% 133
2014
Q3
$66K Buy
700
+600
+600% +$54.1K 0.03% 176
2014
Q2
$9K Buy
+100
New +$7.61K ﹤0.01% 351

Other funds holding CELG

Apriem Advisors's CELG Position: Q3 2018 in Review

Apriem Advisors sold out of Celgene Corp (CELG) in Q3 2018, closing a stake of 1,197 shares — an estimated $95K sold.

Apriem Advisors first reported a position in CELG in Q2 2014 and held it in 15 quarters. The position peaked at $3.13M in Q3 2017. 1,364 funds tracked by Wall St. Rank hold CELG as of Q3 2018.

  • Apriem Advisors reported no remaining Celgene Corp position as of Q3 2018 after selling out during the quarter.
  • Apriem Advisors sold 1,197 Celgene Corp shares in Q3 2018, an estimated $95K.
  • Apriem Advisors first reported a position in Celgene Corp in Q2 2014 and held it in 15 quarters.
  • Apriem Advisors's Celgene Corp position peaked at $3.13M in Q3 2017.
  • 1,364 funds tracked by Wall St. Rank held Celgene Corp as of Q3 2018.

Based on Apriem Advisors's 13F filing for Q3 2018, filed 14 Nov 2018.